Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1999Clinical & Laboratory Haematology

Lifetime treatment costs of β-thalassaemia major

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJonathan KarnonFlinders UniversityDZDagmar ZeunerLondon Borough of SouthwarkJBJ. BrownUniversity of Kentucky

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Karnon et al. (1999) studied this question.

synapsesocial.com/papers/6a7645da4fac453bfeb1bc15https://doi.org/10.1046/j.1365-2257.1999.00262.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults*1995 · 159 citations
  2. 2Effect of different treatment regimes on linear growth and final height in β‐thalassaemia major1994 · 43 citations